Defects in ciliary signaling or mutations in proteins that localize to primary cilia lead to a class of human diseases known as ciliopathies. About 10% of mammalian genes encode cilia-associated proteins and a major gap in the cilia research field is prioritizing which genes to study and finding the in vivo vertebrate mutant alleles and reagents available for their study. Here we present a unified resource listing the cilia-associated human genes cross-referenced to available mouse and zebrafish mutant alleles, their associated phenotypes as well as expression data in kidney and functional data for vertebrate Hedgehog signaling. This resource empowers researchers to easily sort and filter genes based on their own expertise and priorities, cross-reference with newly-generated -omics datasets, and quickly find in vivo resources and phenotypes associated with a gene of interest.
A prioritization tool for cilia-associated genes and their in vivo resources unveil new avenues for ciliopathy research
- Award Group:
- Funder(s): National Institute of General Medical Sciences
- Award Id(s): K12GM000680
- Funder(s):
- Award Group:
- Funder(s): National Institute of Diabetes and Digestive and Kidney Diseases
- Award Id(s): F32DK127848
- Funder(s):
- Award Group:
- Funder(s): National Institute of General Medical Sciences
- Award Id(s): R35GM148416
- Funder(s):
- Award Group:
- Funder(s): National Institute of Diabetes and Digestive and Kidney Diseases
- Award Id(s): R01DK128902
- Funder(s):
- Award Group:
- Funder(s): National Science Foundation
- Award Id(s): BIO DFG 2329634
- Funder(s):
Robert E. Van Sciver, Tamara Caspary; A prioritization tool for cilia-associated genes and their in vivo resources unveil new avenues for ciliopathy research. Dis Model Mech 2024; dmm.052000. doi: https://doi.org/10.1242/dmm.052000
Download citation file:
Advertisement
Cited by
Call for Papers – Infectious Disease: Evolution, Mechanisms and Global Health
Showcase your latest research on our upcoming Special Issue: Infectious Disease: Evolution, Mechanisms and Global Health. This issue will be coordinated by DMM Editors Sumana Sanyal and David Tobin alongside Guest Editors Judi Allen and Russell Vance. The deadline for submitting articles to this Special Issue is Monday 20 January 2025.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate a DMM programme on antimicrobial resistance on 26 March 2025. Find out more and register to join us in March 2025 in Liverpool, UK.
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Other journals from
The Company of Biologists